LDL and HDL subclass distribution in patients with end-stage renal diseases

被引:39
作者
Alabakovska, SB [1 ]
Todorova, BB [1 ]
Labudovic, DD [1 ]
Tosheska, KN [1 ]
机构
[1] Fac Med, Dept Med & Expt Biochem, Skopje, North Macedonia
关键词
end-stage renal disease; low-density lipoprotein subclasses; high density lipoprotein subclasses;
D O I
10.1016/S0009-9120(02)00300-4
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To examine the alterations in LDL and HDL subclass distribution in ESRD patients compared with a control group and to investigate the relationship of LDL particle size to the other plasma lipoproteins levels. Design and methods: Plasma lipids, LDL and HDL subclasses were determined in 63 hemodialysis patients (HD), 42 predialysis patients and 345 control subjects, Lipoprotein subclasses were separated by polyacrylamide 3 to 31% gradient gel electrophoresis. Results: In predialysis group, 88% subjects had small LDL particles compared with 58.5% of hemodialysis patients and 16.5% of control subjects. Mean LDL size particle diameter was significantly smaller in HD and predialysis patients in comparison with controls (p < 0,0005, p < 0,0001; respectively). Significant inverse correlation between LDL particle size and triglyceride level was observed for both patient groups. Decreased levels of the largest HDL2b subclass was found in both predialysis (16.5%) and in HD patients (30%,) as compared with controls (50%), and increased levels of the small HDL3a subclass was found only in predialysis group (21%) in comparison with controls (4.5%). Conclusions: Alterations in LDL and HDL subclass distribution toward smaller particles is the main lipid abnormality associated with atherogensis found in ESRD. ESRD is associated with reduced levels of HDL2b subclass and increased levels of HDL3c subclass, which occurs in coronary artery disease (CAD) as well. (C) 2002 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:211 / 216
页数:6
相关论文
共 26 条
  • [1] Gradient gel electrophoretic separation of LDL and HDL subclasses on BioRad Mini Protean II and size phenotyping in healthy Macedonians
    Alabakovska, SB
    Todorova, BB
    Labudovic, DD
    Tosheska, KN
    [J]. CLINICA CHIMICA ACTA, 2002, 317 (1-2) : 119 - 123
  • [2] Compositional and functional changes of low-density lipoprotein during hemodialysis in patients with ESRD
    Ambrosch, A
    Domroese, U
    Westphal, S
    Dierkes, J
    Augustin, W
    Neumann, KH
    Luley, C
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (02) : 608 - 617
  • [3] Diagnosis and classification of dyslipidemia in renal disease
    Attman, PO
    Samuelsson, O
    Alaupovic, P
    [J]. BLOOD PURIFICATION, 1996, 14 (01) : 49 - 57
  • [4] AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
  • [5] High density lipoproteins and coronary heart disease
    Barter, PJ
    Rye, KA
    [J]. ATHEROSCLEROSIS, 1996, 121 (01) : 1 - 12
  • [6] PREDOMINANCE OF LARGE LDL AND REDUCED HDL(2) CHOLESTEROL IN NORMOLIPIDEMIC MEN WITH CORONARY-ARTERY DISEASE
    CAMPOS, H
    ROEDERER, GO
    LUSSIERCACAN, S
    DAVIGNON, J
    KRAUSS, RM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (08) : 1043 - 1048
  • [7] METHOD FOR QUANTITATING CHOLESTEROL IN SUBFRACTIONS OF SERUM-LIPOPROTEINS SEPARATED BY GRADIENT GEL-ELECTROPHORESIS
    CHENG, ML
    KAMMERER, CM
    LOWE, WF
    DYKE, B
    VANDEBERG, JL
    [J]. BIOCHEMICAL GENETICS, 1988, 26 (11-12) : 657 - 681
  • [8] Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation
    Deighan, CJ
    Caslake, MJ
    McConnell, M
    Boulton-Jones, JM
    Packard, CJ
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) : 852 - 862
  • [9] The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria
    Deighan, CJ
    Caslake, MJ
    McConnell, M
    Boulton-Jones, JM
    Packard, CJ
    [J]. ATHEROSCLEROSIS, 2001, 157 (01) : 211 - 220
  • [10] Increased atherogenicity of low-density lipoprotein in heavy proteinuria
    Deighan, CJ
    Caslake, MJ
    McConnell, M
    Boulton-Jones, JM
    Packard, CJ
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (05) : 1183 - 1188